Creston PLC
17 April 2007
TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES
(1). Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached:
CRESTON GBP0.10
2. Reason for the notification (please state Yes/No): ( )
An acquisition or disposal of voting rights: ( X )
An acquisition or disposal of financial instruments which may result
in the acquisition of shares already issued to which voting rights are
attached: ( )
An event changing the breakdown of voting rights: ( )
Other (please specify) : ( )
3. Full name of person(s) subject to the notification obligation:
AXA S.A. 25 AVENUE MATIGNON, 75008 PARIS AND ITS GROUP OF COMPANIES
4. Full name of shareholder(s) (if different from 3.):
5. Date of the transaction and date on which the threshold is crossed or reached
if different):
16/04/2007
6. Date on which issuer notified:
17/04/2007
7. Threshold(s) that is/are crossed or reached:
10%
8. Notified details:
A: Voting rights attached to shares
Class/type of shares Situation previous to
if possible using the the Triggering
ISIN CODE transaction
Number of shares Number of voting Rights
0444028 5,674,067 5,674,067
Resulting situation after the triggering transaction
Class/type of shares Number of shares Number of voting rights % of voting rights
if possible using
the ISIN CODE
Direct Direct Indirect Direct Indirect
56,138 56,138 5,427,929 0.10 9.74
B: Financial Instruments
Resulting situation after the triggering transaction
Type of Expiration Date Exercise/Conversion Number of voting % of voting
financial Period/ Date rights that may be rights
instrument acquired if the
instrument is
exercised/
converted.
Total (A+B)
Number of voting rights % of voting rights
5,484,067 9.84%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
Name of the Company / Fund Number of Shares % of issued share
capital
AXA UK Investment Co ICVC 179,521 0.32216
UK Smaller Companies Fund
Indirect
AXA Rosenberg 1,445,477 2.59400
Indirect
Sun Life Unit Assurance Ltd 9,817 0.01762
FTSE All Share Tracker
Direct
Sun Life Pensions Management 46,321 0.08312
FTSE All Share Tracker
Direct
AXA Framlington 314,908 0.56512
Xerox Final Salary Pension Scheme
Indirect
AXA Framlington 192,844 0.34607
Islington Group Pension Scheme
Indirect
AXA Framlington 350,000 0.62810
SEl UK Equity
Indirect
AXA Framlington 1,700 000 3.05075
Throgmorton Trust
Indirect
AXA Framlington 800,000 1.43565
UK Smaller Companies
Indirect
AXA Framlington 314,480 0.56435
BAE Systems Pensions Fund CIF Trustees
Indirect
AXA Framlington 130,699 0.23465
BAE Systems 2000 Pensions Fund
Indirect
Total Direct 56,138 0.10074
Total Indirect 5,427,929 9.74076
TOTAL 5,484,067 9.84150
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name:
TERRY MARSH
15. Contact telephone number:
020 7003 2637
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.